Introduction
An exogenous expression system of a gene whose product itself is cytotoxic provides a useful means of not only investigating the physiological role of the gene product in vivo but also of developing a novel strategy for cancer gene therapy as well as for suppression of immune reactions. Construction of a recombinant adenovirus expressing such a gene product, however, is in most cases challenging, because the cytotoxic substance produced may kill the transfected 293 cells, which provide a place to generate recombinant adenoviruses.
Fas-ligand is a potent inducer of apoptosis for cells expressing Fas on their cell surface membrane. 1 Apoptosis of hepatocytes induced by the Fas-mediated pathway is supposed to be an essential trigger in developing fulminant or acute viral hepatitis. 2 Moreover, several recent reports have shown great potential in applying Fas-ligand gene transduction to reduce immune reactions in rejection of allogeneic transplanted organs. [3] [4] [5] [6] Our initial attempt to construct an E1/E3-deleted adenovirus expressing rat Fas-ligand under the control of the CAG promoter 7 was unsuccessful, because the transfected 293 cells rapidly induced apoptosis. Later we found that the 293 cells expressed Fas. To avoid apoptotic
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Received 8 January 1998; accepted 16 March 1998 death in the transfected 293 cells, we chose a conditional expression system using Cre-loxP site-specific recombination. In the Fas-ligand expression cassette, we placed a stuffer sequence between the CAG promoter and cDNA, which prevented its expression during generation of recombinant adenovirus vectors. We also placed two loxP sequences in both ends of the stuffer sequence, which would be removed only in the presence of the Cre recombinase. 8 This vector system has the advantage of being able to construct recombinant adenovirus expressing genes producing cytotoxic substances in 293 cells. We have successfully generated a recombinant adenovirus to express rat Fas-ligand, AxCALNFasL. To supply a high level of Cre recombinase in rodent liver, we used AxCANCre, another adenovirus vector expressing Cre recombinase under the control of the CAG promoter. 9 In this article, we demonstrate efficient transgene expression in rodent liver by co-infection of AxCALNFasL and AxCANCre, with the level of expression being adjustable by the amount of injected AxCANCre.
Result
Fas-mediated apoptosis in 293 cells induced by Fasligand expression Our initial attempt to construct a recombinant adenovirus expressing rat Fas-ligand was unsuccessful. The usual method to construct an expression vector on the E1/E3-deleted adenovirus backbone is that 293 cells are transfected with DNA of a plasmid carrying an expression cassette for a gene of interest together with adenoviral DNA. Since the 293 cells provide the E1 gene product, adenoviral DNA replication occurs and a recombinant adenovirus is generated by DNA recombination between the two DNA molecules. Since a cosmid carrying the entire adenovirus genome is also available at present, the expression cassette is directly inserted into the adenoviral genome by ligation. Recombinant adenoviruses are recovered after transfection of the cosmid DNA together with the adenoviral terminal protein complex. We followed the latter construction method, and transfected 293 cells with DNA isolated from a cosmid 'pAxCAFasL' which carried an intact expression cassette of rat Fas-ligand under the control of the CAG promoter ( Figure 1a) . However, no adenoviruses were generated (Figure 2a) . Moreover, FACS analysis using the anti-human Fas antibody showed endogenous Fas-ligand expression in the 293 cells (Figure 2b ). These observations indicated that the formation and propagation of adenovirus vector expressing Fas-ligand seemed to be difficult in the 293 cells because of Fas-mediated apoptosis. recombinant adenovirus, AxCALNFasL. Since the loxP sequences were also placed in both ends of the stuffer sequence of pAxCALNFasL, the stuffer sequence was expected to be removed with Cre recombinase (Figure 1c ). This was confirmed by DNA analyses after infection of COS-7 cells, a Fas-negative cell line derived from monkey kidney, with the AxCALNFasL recombinant adenovirus together with or without AxCANCre, another recombinant adenovirus expressing Cre recombinase. A 1.8 kb DNA fragment generated by the use of the primer set in PCR corresponds to the original sequence in the cosmid, thus keeping the stuffer sequence intact, while a 0.5 kb fragment generated by the same PCR condition corresponds to the sequence without the stuffer. As shown in Figure 3 , a DNA sample isolated from the cells infected with both adenoviruses (lane 1) generated the 0.5 kb fragment in addition to the 1.8 kb fragment, while DNA isolated from the cells infected with AxCALNFasL alone generated only the 1.8 kb fragment. Thus, at least a fraction of the infected AxCALNFasL adenovirus had lost the stuffer sequence in infected cells. 
Cell-killing effect of exogenous Fas-ligand expression in HepG2 cells
HepG2 is an established cell line from human hepatocellular carcinoma. We previously confirmed the endogenous Fas expression on the cells (data not shown). To investigate whether infection with AxCALNFasL and AxCANCre was able to induce suicide in cancer cells, HepG2 cells was infected with both adenoviruses. When we infected the cells with AxCALNFasL (multiplicity of infection (MOI) 5.0) and AxCANCre (MOI 1.0), most of the cells were dead within 24 h (Figure 5b ). This cell-killing effect was dependent on the dose of AxCANCre and the level of Fas-ligand expression (Figure 5a ). These findings suggest that this vector can be applied to cancer gene therapy.
In vivo expression of Fas-ligand in rodent liver infected with AxCALNFasL Fas-mediated apoptosis of hepatocytes induces lethal acute liver failure. 10 To evaluate the effect of exogenous Fas-ligand expression on the liver, we injected AxCALNFasL and AxCANCre into Balb/c or MRL/lpr mice (congenital Fas-deficient mice) via the tail vein. As shown in Table 1 , we divided the mice into four groups based on the titers of injected adenoviruses and mouse strain. The mice in group II showed extremely high serum aspartate aminotransferase (AST) levels at 16-24 h after the viral injection, and 70% of the mice were dead within 48 h (Figure 6b ). Many apoptotic hepatocytes were observed with the TUNEL nick-end labeling method (Figure 6c ) in the liver of mice 4 days after the viral administration. The development of fulminant hepatitis was also histologically confirmed with hematoxylin-eosin (HE) staining of the liver (data not shown). Observation of fewer apoptotic hepatocytes in group III than in group II mice was consistent with the results of the serum AST concentrations and the survival rates (Figure 6c ). No deleterious effects on the liver were observed in the MRL/lpr mice (group I), suggesting that Fas-mediated apoptosis was responsible for the development of hepatitis in group II and group III mice. These observations showed that efficient and dose-dependent transgene expression was achieved in the rodent liver by co-infection of both adenovirus vectors.
Discussion
In this article, we describe that an adenovirus vector expressing rat Fas-ligand was successfully generated using a Cre-loxP recombination system. Although other laboratories have generated adenovirus vectors expressing Fas-ligand without the conditional expression system, they also pointed out potential problems in the generation of the vectors. [11] [12] [13] [14] Muruve et al 13 constructed an adenovirus vector expressing murine Fas-ligand under the control of the cytomegalovirus promoter. The titer of the virus was five to 10 times lower than that seen with other replication-deficient adenovirus vectors produced in their laboratory, because infection of the seed virus resulted in rapid cell death within 8-12 h and propagation of the virus was prevented. Arai et al 12 used a Fasligand-resistant subclone derived from the 293 cells to produce high titer of an adenovirus vector expressing Fas-ligand. The Cre/loxP vector system described here has the advantage of being able to construct recombinant adenovirus expressing genes producing cytotoxic substances, and we successfully generated a high-titer adenovirus vector expressing rat Fas-ligand without any additional treatment. This vector system, however, has a disadvantage in that site-specific recombination by Cre recombinase is essential in expressing Fas-ligand on the cells infected with AxCALNFasL. We also used an AxCANCre recombinant adenovirus to express Cre recombinase in the liver, since an adenoviral vector system is able to obtain high gene transduction efficiency in the liver and also multiple infections to hepatocytes. 15 As we expected, intravenous administration of AxCANCre and AxCALNFasL was enough to obtain efficient Fasligand expression in the liver.
Suicide gene transduction is one of the most promising strategies for cancer gene therapy, but most of the methods developed so far have been indirect, such as a combination of expression of herpes simplex thymidine kinase in target cells with systemic administration of ganciclovir as a prodrug. [16] [17] [18] In those strategies, ganciclovir is converted into an active form with the thymidine kinase expressed in cancer cells. The method described here, however, provides a straightforward strategy for suicide gene therapy. Since some cancer cells express Fas on their cell surface membranes, 19 simple administration of constructed adenoviruses AxCALNFasL and AxCANCre may kill them, as we demonstrated here with HepG2. 12, 20, 21 Most of the mice injected with an agonistic anti-Fas antibody via the tail vein were killed within 6 h by acute liver failure, and pathological changes of the mice resembled fulminant hepatitis. 7 Kondo et al 2 reported that Fas-mediated apoptosis was an essential trigger for the development of hepatitis. Since the mice administered with AxCALNFasL and AxCANCre also showed clinical and pathological changes close to fulminant or acute hepatitis, these mice should provide excellent models to study pathogenesis of hepatitis and the process of liver regeneration or to develop novel methods for the treatment of fulminant hepatitis. 22, 23 This vector system may also be applicable to reducing c b a Figure 6 Deleterious effect of exogenous Fas-ligand expression on the liver. The mice were divided into four groups based on the titers of the injected adenoviruses and mouse strain (see Table 1 immune response in allogeneic transplantation. Several reports have shown that Fas-ligand is important for the immune privileged sites to escape from deleterious immune responses in allogeneic transplantation. 4, 5 Lau et al 24 showed the preventive effect of Fas-ligand on rejection in allogeneic pancreatic islet transplantation. We recently demonstrated the prolonged survival of rats with transplanted allogeneic liver expressing Fas-ligand using an HVJ-liposome gene transfer system. 25 Although controversial results have also been reported, 11, 26 these observations suggest that if allografts can express a certain level of Fas-ligand by simultaneous administration of AxCALNFasL and AxCANCre, the transplanted allografts may behave just like immune privileged grafts and their survival may be dramatically improved.
Materials and methods
Generation of recombinant adenovirus expressing rat Fas-ligand A recombinant adenovirus vector AxCALNFasL was constructed based on the COS-TPC method described previously. 27 Briefly, the cosmid containing a Cremediated switching expression cassette pAxCALNFasL was constructed by cloning of cDNA for rat Fas-ligand at a unique SwaI site of pAxCALNLw. 9 293 Cells were cotransfected with cosmid pAxCALNFasL and the adenovirus DNA-terminal protein complex digested at several sites with EcoT22I. A recombinant adenovirus AxCALNFasL was generated through homologous recombination in the 293 cells.
FACS analysis of Fas expression in 293 cells
Cultured 5 × 10 5 cells were harvested and suspended with 1 ml PBS. After centrifugation, PBS with an antiFas antibody, ZB4 (MBL, Nagoya, Japan), was added at a dilution of 1:250, incubated for 20 min at 4°C, followed by two rinses with PBS. One hundred microliters of fluorescein isothiocyanate (FITC)-conjugated rabbit antimouse IgG (STAR9B; Serotec, Oxford, UK) at a 1:100 dilution was then added, incubated for another 15 min at 4°C, and rinsed as above. The cells were resuspended in 1 ml PBS and analyzed using flow cytometry (FACScan; Becton Dickinson, Mountain View, CA, USA).
Western blotting for detection of rat Fas-ligand COS-7 cells and HepG2 cells were lysed in SDS-PAGE lysis buffer (150 mm NaCl, 1% Triton X100, 5 mm EDTA, 10 mm Tris-HCl, pH 7.4 and 10 g/ml aprotinin). Samples were fractionated through a 12% acrylamide gel by SDS-PAGE and then transferred to nitrocellulose filters. The filters were blocked with TBST buffer (10 mm Tris-HCl, pH 8.0, 0.15 m NaCl, 0.05% Tween 20) containing 5% skimmed milk and incubated with a rabbit antihuman Fas-ligand antibody (sc-956; Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 1:250 for 2 h at room temperature. Horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (sc-2004; Santa Cruz Biotechnology) was used as a second antibody at 1:500 for 2 h at room temperature. Filters were washed in TBST buffer four times for 10 min. Immune complexes were detected using the ECL chemiluminescence method (Amersham, Buckinghamshire, UK).
Determination of serum AST concentration Serum AST concentrations were determined using a Vision kit (Abbott, Abbott Park, IL, USA) according to the manufacturer's protocol.
Histochemical detection of apoptotic cells in liver
Apoptotic cells in rodent liver were detected based on the TUNEL nick-end labelling method using an Apop Tag plus kit (Oncor, Gaithersburg, MD, USA). Cryosections (6 m) were cut and fixed in 10% neutral buffered formalin in a coplin jar. The sections were treated in 2-3% hydrogen peroxide in PBS for 5 min at room temperature, then incubated with terminal deoxynucleotidyl transferase (TdT) reaction mixture consisting of 38 l reaction buffer and 16 l TdT enzyme in a humidified chamber at 37°C for 1 h. The reaction was terminated with pre-warmed stop/wash buffer for 30 min at 37°C. For visualization of incorporated TdT, sections were incubated with a peroxidase-conjugated anti-digoxigenin antibody for 30 min at room temperature. Sections were washed three times in a coplin jar and incubated with DAB substrate solution for 3-6 min. The reaction was terminated by washing with H 2 O, and sections were counterstained with hematoxylin and mounted.
PCR detection of the transgene sequences of infected COS-7 cells with adenoviruses
The primers to amplify the transgene sequences with AxCALNFasL were synthesized based on the sequences of the CAG promoter and Fas-ligand cDNA. The sequences of the forward and reverse primers were 5′-ATCTGGCGGAGCCGAAATCT-3′, and 5′-CCCAGTA-GATCTGGGGACAT-3′, respectively. One hundred microliters of the reaction mixture contained 250 m of dNTPs, 10 pmol of the forward and reverse primers, 1 g of purified DNA from the cells, and 2.5 U Taq DNA polymerase (TaKaRa, Shiga, Japan). Forty cycles of the PCR reactions were carried out at 94°C for 30 s, 60°C for 30 s, and 72°C for 90 s. The PCR products were analyzed on 1.5% agarose gels.
